L'Oréal's 7% India share forced a playbook rewrite — $350M for D2C brand Innovist

L'Oréal spent two decades in India with a playbook built on premium European brands and mass-priced staples — Garnier sachet hair colour, Aishwarya Rai's 'five problems, one solution' — while the beauty and personal care market grew from $15 billion in 2015 to $23 billion in 2025 (Redseer estimates), mostly on venture-backed, digital-first local brands. L'Oréal India's revenue grew from ₹3,310 crore in FY19 to ₹5,980 crore in FY25, a CAGR of just over 10%, but market share stood at 7% — about half its average in most countries, managing director Jacques Lebel said in April.

In February, global CEO Nicolas Hieronimus told analysts he was unhappy with the stagnant market, where India is about 1% of group revenue. Lebel is already the third India managing director in eight years, after Amit Jain (2018-2023) and Aseem Kaushik (2023-2025), hired for his mass-market and turnaround experience.

The correction came late and expensive. The dermatological beauty vertical only launched in India in 2023 with CeraVe, Lancôme returned the year before, and La Roche-Posay arrived late in 2025. The centrepiece came in June 2026: L'Oréal bought a majority of Innovist — Chemist At Play, Bare Anatomy and Sunscoop's owner — at roughly $350 million by Mint's sources, rich pricing for a company with about ₹300 crore of FY25 revenue, a banker said. One investor told Mint L'Oréal lacks the DNA to capture niches the way India's D2C brands do; Lebel conceded it is 'not an expert' at D2C websites.

Rivals had moved earlier: Hindustan Unilever acquired Minimalist and OZiva after its own incubated digital brands stalled, and Marico expanded Plix. L'Oréal is also a limited partner in Fireside Ventures and DSG Consumer Partners and runs its own BOLD fund, which invested in skincare brand Chosen and in 2026 partnered with Nykaa to back beauty brands.

7% market share — about half its average in most countries; ~$350M for a majority of Innovist, which had scaled to about ₹300 crore revenue in FY25

The India business stayed on a premium-import, general-trade playbook while VC-backed D2C brands built ingredient-led niches online first.

L'Oréal launched its dermatological and luxury verticals years late — 2022 to 2023 — in a market growing north of 10% a year.

Three India managing directors in eight years signalled a strategy that never stuck.

It ended up paying a reported ~$350M — a rich multiple for a ₹300-crore-revenue startup — to acquire the D2C capabilities and niches it failed to build itself.

Incumbents that ride a premium import playbook can lose a fast-premiumizing market to local digital-first brands — then pay rich multiples to buy back the niches they missed.

Lebel told Mint the company wants to 'significantly beat' the market's expected 10%-plus growth and said 'so far we are on track, and happy with the performance.' A banker who has worked with L'Oréal said the company has seen more assets but is being cautious 'because they need to digest Innovist first,' and that India's consumer multiples run 60-70% above global benchmarks. On an investor call in July, Hieronimus named India among the two top-performing markets in its SAPMENA region, while flagging skincare as the category where it still has to accelerate.